Sign In
Buy AMED
$100.99
+0 (+0%)
At Close: Nov 13, 2025
Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger
11:55am, Friday, 27'th Dec 2024
UnitedHealth Group (UNH) and Amedisys (AMED) agreed to extend the deadline to complete their $3.3 billion merger, after the U.S. Department of Justice moved to block it.
Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?
11:11am, Friday, 27'th Dec 2024
Amedisys Inc AMED shares are trading higher on Friday after the company announced it extended its merger deadline with UnitedHealth Group Incorporated UNH.
DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal
11:25am, Wednesday, 13'th Nov 2024
The DOJ suggests that UNH's acquisitions reflect a strategy of buying competitors rather than competing directly, potentially giving it control over multiple markets.
US sues to block UnitedHealth's $3.3 bln purchase of Amedisys
12:03pm, Tuesday, 12'th Nov 2024
The Justice Department and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc over concern the deal would harm competition in the market f
US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports
09:14am, Tuesday, 12'th Nov 2024
The U.S. Justice Department is moving to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc. over concerns the deal would harm competition in the market for home health services, Bloombe
AMED Q3 Earnings and Revenues Miss, Margins Dip, Stock Falls
09:40am, Monday, 11'th Nov 2024
Amedisys, for the third quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.
Amedisys (AMED) Reports Q3 Earnings: What Key Metrics Have to Say
10:30pm, Wednesday, 06'th Nov 2024
Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall St
Amedisys (AMED) Q3 Earnings and Revenues Lag Estimates
08:11pm, Wednesday, 06'th Nov 2024
Amedisys (AMED) came out with quarterly earnings of $1 per share, missing the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $0.98 per share a year ago.
Amedisys Reports Third Quarter 2024 Financial Results
04:30pm, Wednesday, 06'th Nov 2024
BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024.
AMED or CHE: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 04'th Nov 2024
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Amedisys (AMED) and Chemed (CHE). But which of these two companies is the best op
4 Stocks to Buy in an Evolving Outpatient Home Health Industry
12:05pm, Wednesday, 23'rd Oct 2024
Dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, AMED and ADUS are well-poised
Will Amedisys (AMED) Beat Estimates Again in Its Next Earnings Report?
01:15pm, Wednesday, 16'th Oct 2024
Amedisys (AMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AMED vs. CHE: Which Stock Is the Better Value Option?
12:45pm, Wednesday, 16'th Oct 2024
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Amedisys (AMED) and Chemed (CHE). But which of these two stocks is more attractiv
Amedisys (AMED) Moves to Buy: Rationale Behind the Upgrade
01:00pm, Monday, 30'th Sep 2024
Amedisys (AMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AMED or CHE: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 30'th Sep 2024
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and Chemed (CHE). But which of these two stocks presents investors with the better valu
